AIMS/HYPOTHESIS: Insulin-sensitive tissues (muscle, liver) of individuals with obesity and type 2 diabetes mellitus are in a state of low-grade inflammation, characterised by increased Toll-like receptor (TLR) expression and TLR-driven signalling. However, the cause of this mild inflammatory state is unclear. We tested the hypothesis that a prolonged mild increase in plasma NEFA will increase TLR expression and TLR-driven signalling (nuclear factor κB [NFκB] and mitogen-activated kinase [MAPK]) and impair insulin action in muscle of lean healthy individuals. METHODS:Twelve lean, normal-glucose-tolerant participants were randomised to receive a 48 h infusion (30 ml/h) of saline or Intralipid followed by a euglycaemic-hyperinsulinaemic clamp. Vastus lateralis muscle biopsies were performed before and during the clamp. RESULTS: Lipid infusion impaired insulin-stimulated IRS-1 tyrosine phosphorylation and reduced peripheral insulin sensitivity (p < 0.01). The elevation in circulating NEFA increased expression of TLR3, TLR4 and TLR5, and several MAPK (MAPK8, MAP4K4, MAP2K3) and inhibitor of κB kinase-NFκB (CHUK [IKKA], c-REL [REL] and p65 [RELA, NFKB3, p65]) signalling genes (p < 0.05). The lipid infusion also increased extracellular signal-regulated kinase (ERK) phosphorylation (p < 0.05) and tended to reduce the content of inhibitor of kappa Bα (p = 0.09). The muscle content of most diacylglycerol, ceramide and acylcarnitine species was unaffected. In summary, insulin resistance induced by prolonged low-dose lipid infusion occurs together with increased TLR-driven inflammatory signalling and impaired insulin-stimulated IRS-1 tyrosine phosphorylation. CONCLUSIONS/ INTERPRETATION: A sustained, mild elevation in plasma NEFA is sufficient to increase TLR expression and TLR-driven signalling (NFκB and MAPK) in lean individuals. The activation of this pathway by NEFA may be involved in the pathogenesis of insulin resistance in humans. TRIAL REGISTRATION: ClinicalTrials.gov NCT01740817.
RCT Entities:
AIMS/HYPOTHESIS: Insulin-sensitive tissues (muscle, liver) of individuals with obesity and type 2 diabetes mellitus are in a state of low-grade inflammation, characterised by increased Toll-like receptor (TLR) expression and TLR-driven signalling. However, the cause of this mild inflammatory state is unclear. We tested the hypothesis that a prolonged mild increase in plasma NEFA will increase TLR expression and TLR-driven signalling (nuclear factor κB [NFκB] and mitogen-activated kinase [MAPK]) and impair insulin action in muscle of lean healthy individuals. METHODS: Twelve lean, normal-glucose-tolerant participants were randomised to receive a 48 h infusion (30 ml/h) of saline or Intralipid followed by a euglycaemic-hyperinsulinaemic clamp. Vastus lateralis muscle biopsies were performed before and during the clamp. RESULTS:Lipid infusion impaired insulin-stimulated IRS-1tyrosine phosphorylation and reduced peripheral insulin sensitivity (p < 0.01). The elevation in circulating NEFA increased expression of TLR3, TLR4 and TLR5, and several MAPK (MAPK8, MAP4K4, MAP2K3) and inhibitor of κB kinase-NFκB (CHUK [IKKA], c-REL [REL] and p65 [RELA, NFKB3, p65]) signalling genes (p < 0.05). The lipid infusion also increased extracellular signal-regulated kinase (ERK) phosphorylation (p < 0.05) and tended to reduce the content of inhibitor of kappa Bα (p = 0.09). The muscle content of most diacylglycerol, ceramide and acylcarnitine species was unaffected. In summary, insulin resistance induced by prolonged low-dose lipid infusion occurs together with increased TLR-driven inflammatory signalling and impaired insulin-stimulated IRS-1tyrosine phosphorylation. CONCLUSIONS/ INTERPRETATION: A sustained, mild elevation in plasma NEFA is sufficient to increase TLR expression and TLR-driven signalling (NFκB and MAPK) in lean individuals. The activation of this pathway by NEFA may be involved in the pathogenesis of insulin resistance in humans. TRIAL REGISTRATION: ClinicalTrials.gov NCT01740817.
Authors: William L Holland; Benjamin T Bikman; Li-Ping Wang; Guan Yuguang; Katherine M Sargent; Sarada Bulchand; Trina A Knotts; Guanghou Shui; Deborah J Clegg; Markus R Wenk; Michael J Pagliassotti; Philipp E Scherer; Scott A Summers Journal: J Clin Invest Date: 2011-04-01 Impact factor: 14.808
Authors: O P Bachmann; D B Dahl; K Brechtel; J Machann; M Haap; T Maier; M Loviscach; M Stumvoll; C D Claussen; F Schick; H U Häring; S Jacob Journal: Diabetes Date: 2001-11 Impact factor: 9.461
Authors: John M Miles; David Wooldridge; Wayne J Grellner; Sheryl Windsor; William L Isley; Samuel Klein; William S Harris Journal: Diabetes Date: 2003-03 Impact factor: 9.461
Authors: Joo Y Lee; Anthony Plakidas; Won H Lee; Anne Heikkinen; Prithiva Chanmugam; George Bray; Daniel H Hwang Journal: J Lipid Res Date: 2002-12-01 Impact factor: 5.922
Authors: Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey Journal: J Nutr Date: 2009-04-15 Impact factor: 4.798
Authors: Andrew J Hoy; Amanda E Brandon; Nigel Turner; Matthew J Watt; Clinton R Bruce; Gregory J Cooney; Edward W Kraegen Journal: Am J Physiol Endocrinol Metab Date: 2009-04-14 Impact factor: 4.310
Authors: M Jawad Khan; Carolina B Jacometo; Mario Vailati Riboni; Erminio Trevisi; Daniel E Graugnard; Marcio N Corrêa; Juan J Loor Journal: Funct Integr Genomics Date: 2015-05-05 Impact factor: 3.410
Authors: Oh Sung Kwon; Daniel S Nelson; Katherine M Barrows; Ryan M O'Connell; Micah J Drummond Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-08-31 Impact factor: 3.619
Authors: Cathryn M Kolka; Joyce M Richey; Ana Valeria B Castro; Josiane L Broussard; Viorica Ionut; Richard N Bergman Journal: Am J Physiol Endocrinol Metab Date: 2015-04-07 Impact factor: 4.310
Authors: Oh Sung Kwon; Ruth E Tanner; Katherine M Barrows; Marah Runtsch; J David Symons; Thunder Jalili; Benjamin T Bikman; Donald A McClain; Ryan M O'Connell; Micah J Drummond Journal: Am J Physiol Endocrinol Metab Date: 2015-05-12 Impact factor: 4.310
Authors: Nicolas J Pillon; Scott Frendo-Cumbo; Maya R Jacobson; Zhi Liu; Paul L Milligan; Hai Hoang Bui; Juleen R Zierath; Philip J Bilan; Joseph T Brozinick; Amira Klip Journal: J Lipid Res Date: 2018-05-23 Impact factor: 5.922